ES2033212A6 - Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados. - Google Patents
Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.Info
- Publication number
- ES2033212A6 ES2033212A6 ES08904164A ES8904164A ES2033212A6 ES 2033212 A6 ES2033212 A6 ES 2033212A6 ES 08904164 A ES08904164 A ES 08904164A ES 8904164 A ES8904164 A ES 8904164A ES 2033212 A6 ES2033212 A6 ES 2033212A6
- Authority
- ES
- Spain
- Prior art keywords
- pct
- date
- production
- ancrod
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Procedimiento para la obtención de péptidos puramente glicosilados, parcialmente glicosilados o no glicosilados con la secuencia de aminoácidos: 1 viggdecnin ehrflvavye gtx 1 wtficgg vlihpewvit aehcarrrmn 51 lvfgmhrkse kfddeqeryp kkryfircx 2k trtswdedim lirlnkpvx 3n 101 sehiaplslp snppivgsdc rvmgwgsinr rihvlsdepr caninlhx 4ft 151 mchglfrkmp kkgrvlcagd lrgrrdscns dsggplicne elhgivargp 201 npcaqpnkpa lytsvydyrd wvnnviagx 5a tcsp Comprende aislar el mRNA de un organismo adecuado; traducirlo en cDNA de doble hebras; aplicar este cDNA en un vector de clonación; y aplicar posteriormente una biblioteca cDNA, para expresar así secuencias de DNA en dicho organismo huesped que codifiquen las secuencias de péptido anteriormente indicados. Los péptidos son adecuados para la lucha contra enfermedades.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3841736A DE3841736A1 (de) | 1988-12-10 | 1988-12-10 | Ancrod-proteine, ihre herstellung und verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2033212A6 true ES2033212A6 (es) | 1994-05-01 |
Family
ID=6368940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES08904164A Expired - Lifetime ES2033212A6 (es) | 1988-12-10 | 1989-12-07 | Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6015685A (es) |
EP (1) | EP0447468B1 (es) |
JP (1) | JP2783296B2 (es) |
AT (1) | ATE123056T1 (es) |
AU (1) | AU637589B2 (es) |
BR (1) | BR1100940A (es) |
CA (1) | CA2004764C (es) |
DE (2) | DE3841736A1 (es) |
ES (1) | ES2033212A6 (es) |
HU (1) | HU211658A9 (es) |
WO (1) | WO1990006362A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759541A (en) * | 1990-07-26 | 1998-06-02 | Basf Aktiengesellschaft | Recombinant fibrinogenases, the preparation and use thereof |
DE4023699A1 (de) * | 1990-07-26 | 1992-01-30 | Basf Ag | Neue proteine, ihre herstellung und verwendung |
DE19729544A1 (de) | 1997-07-10 | 1999-01-14 | Basf Ag | Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung |
US20030219431A1 (en) * | 2002-05-24 | 2003-11-27 | Empire Pharmaceuticals, Inc. | Treatment of neuronal and neurological damage associated with spinal cord injury |
CN108559740B (zh) * | 2018-05-12 | 2021-05-18 | 吉林天衡康泰生物技术有限公司 | 重组安克洛酶及工业规模制备方法和治疗急性脑梗的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3879369A (en) * | 1972-05-12 | 1975-04-22 | Abbott Lab | Anti-coagulant isolation from malayan pit viper using affinity chromatography |
DE2615844A1 (de) * | 1976-04-10 | 1977-10-20 | Knoll Ag | Fibrinogen spaltendes enzymsystem |
ZA889415B (en) * | 1987-12-18 | 1989-09-27 | Chiron Corp | Compositions and method for recombinant production of crotalidus venum fibrolase |
CA2015127A1 (en) * | 1989-04-26 | 1990-10-26 | John G. Gray, Jr. | Novel dna sequences which encode ancrod-like polypeptides and compositions comprising the expression products thereof |
DE4023699A1 (de) * | 1990-07-26 | 1992-01-30 | Basf Ag | Neue proteine, ihre herstellung und verwendung |
-
1988
- 1988-12-10 DE DE3841736A patent/DE3841736A1/de not_active Withdrawn
-
1989
- 1989-11-25 DE DE58909261T patent/DE58909261D1/de not_active Expired - Lifetime
- 1989-11-25 JP JP2501006A patent/JP2783296B2/ja not_active Expired - Lifetime
- 1989-11-25 AU AU46644/89A patent/AU637589B2/en not_active Expired
- 1989-11-25 AT AT90900807T patent/ATE123056T1/de not_active IP Right Cessation
- 1989-11-25 US US07/690,957 patent/US6015685A/en not_active Expired - Lifetime
- 1989-11-25 EP EP90900807A patent/EP0447468B1/de not_active Expired - Lifetime
- 1989-11-25 WO PCT/EP1989/001427 patent/WO1990006362A1/de active IP Right Grant
- 1989-12-06 CA CA002004764A patent/CA2004764C/en not_active Expired - Lifetime
- 1989-12-07 ES ES08904164A patent/ES2033212A6/es not_active Expired - Lifetime
-
1995
- 1995-06-30 HU HU95P/P00710P patent/HU211658A9/hu unknown
-
1997
- 1997-05-14 BR BR1100940-3A patent/BR1100940A/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BR1100940A (pt) | 2000-08-01 |
JP2783296B2 (ja) | 1998-08-06 |
CA2004764A1 (en) | 1990-06-10 |
EP0447468A1 (de) | 1991-09-25 |
DE3841736A1 (de) | 1990-07-05 |
CA2004764C (en) | 1999-07-06 |
WO1990006362A1 (de) | 1990-06-14 |
HU211658A9 (en) | 1995-12-28 |
AU4664489A (en) | 1990-06-26 |
EP0447468B1 (de) | 1995-05-24 |
DE58909261D1 (de) | 1995-06-29 |
JPH04502252A (ja) | 1992-04-23 |
ATE123056T1 (de) | 1995-06-15 |
AU637589B2 (en) | 1993-06-03 |
US6015685A (en) | 2000-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0158286A3 (en) | A novel human physiologically active polypeptide | |
DE69533556D1 (de) | N-terminal modifizierte Polypeptide, und Herstellungsprozess | |
ATE257859T1 (de) | Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit | |
HU9200548D0 (en) | Improved activity process of recombined proteins | |
WO2000034474A3 (en) | Growth factor homolog zvegf3 | |
NZ503235A (en) | Amino-terminally truncated RANTES as chemokine antagonists | |
TW275066B (es) | ||
DK0446315T3 (da) | Fremgangsmåde til fremstilling af PAI-2 | |
AU637589B2 (en) | Ancrod proteins, their production and use | |
AU590861B2 (en) | New human lymphotoxin (TNF-beta) polypeptides their prepartion and use | |
CA2056467A1 (en) | Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations | |
ES8605296A1 (es) | Procedimiento de producir factor viii-r humano | |
EP0723016A3 (en) | Leukocyte activation factor | |
WO1992001794A3 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung | |
DE68916559D1 (de) | Polypeptide und dafür kodierende DNA. | |
DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA2A | Application withdrawn |
Effective date: 19930920 |